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Background:  Right ventricular (RV) function is an important predictor in the course of chronic thromboembolic pulmonary hypertension 
(CTEPH). Recently, balloon pulmonary angioplasty (BPA) has been reported to improve hemodynamics and functional capacity in patients 
with CTEPH. However, there are no reports whether BPA improves the right ventricular systolic and diastolic functions. We prospectively 
investigated whether BPA in patients with inoperable CTEPH improves the right ventricular systolic and diastolic functions with cardiac 
echocardiography.
methods and results:  We studied 30 consecutive patients with inoperable CTEPH (9 males and 21 females, mean age 67.4±0.6 [SD] 
years) who underwent BPA. Their mean right ventricular ejection fraction was 38.6% (range, 24.0-38.8%) by magnetic resonance imaging. 
All patients underwent clinical and laboratory examination, standard echocardiography completed by the Doppler tissue imaging (TDI) 
of the tricuspid valve annular motion from the apical 4-chamber view, and the right-sided heart catheterization (RHC) before and after 
BPA. We compared these parameters between before and after BPA. BPA significantly reduced mean pulmonary arterial pressure (PAP) 
(34.9±12.5mmHg vs. 28.9±7.9mmHg, p<0.001), and significantly improved stroke volume (55.1±19.8ml vs. 64.6±22.3ml, p<0.005). There 
were similar volume status before and after BPA (right atrial pressure, 2.3±1.9mmHg vs. 2.0±1.2mmHg, p=0.42). In RV systolic functional 
parameters, tricuspid annular plane systolic excursion (TAPSE), peak systolic tricuspid annular velocity (Sa) and fractional area change 
(FAC) were not significantly different between before and after BPA (TAPSE, 18.1±4.0mm vs. 18.6±5.0mm, p=0.46, Sa, 11.3±2.4cm/sec 
vs. 11.8±3.4cm/sec, p=0.56, FAC, 29.8±12.9% vs. 28.9±10.9%, p=0.42). However, in RV diastolic functional parameters, only peak early 
diastolic tricuspid annular velocity (Ea) significantly improved after BPA (6.8±2.2cm/sec vs. 7.8±2.5cm/sec, p<0.005).
conclusion:  This study suggests that BPA in patients with inoperable CTEPH improved not only mean PAP and stroke volume but also 
the parameter of RV diastolic function.
